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Abstract
Background: Previous studies of HIV acquisition in pregnancy have been in specific population groups, such as
sero-discordant couples which have shown an increased risk of HIV acquisition during pregnancy and studies of
sexually active women where the results have been ambiguous. However these studies are unable to tell us what the
overall impact of pregnancy is on HIV acquisition in the general population.
Methods: Data from six community-based HIV cohorts were pooled to give 2,628 sero-conversions and a total of
178,000 person years of observation. Multiple imputation was used to allow for the uncertainty of exact sero-
conversion date in surveillance intervals greater than the length of a pregnancy. Results were combined using
Rubin’s rules to give appropriate error bounds. The analysis was stratified into two periods: pre- and post-
widespread availability of prevention of mother-to-child HIV transmission services. This allows us to assess whether
there is reporting bias relating to a person’s knowledge of their own HIV status which would become more
widespread in the latter time period.
Results: Results suggest that women while pregnant have a lower risk of acquiring HIV infection over all periods
(HRR 0.79, 95%CI 0.70-0.89) than women who were not pregnant. There is no evidence for a difference in the rate
of HIV acquisition between postpartum and non-pregnant women (HRR 0.92 95%CI 0.84-1.03).
Discussion: Although there may be immunological reasons for increased risk of HIV acquisition during pregnancy, at
a population level this study indicates a lower risk of HIV acquisition for pregnant women. Pregnant women may be
more likely to be concordant with their current sexual partner than non-pregnant women, i.e. either already HIV
positive prior to the pregnancy or if negative at the time of becoming pregnant more likely to have a negative partner.
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Introduction
Fertility rates are high in many sub-Saharan African
countries and, thus, a significant proportion of woman-years
are spent pregnant [1]. Evidence regarding the risk of
acquisition of HIV infection at and shortly after the time of
pregnancy is conflicting [2-8]. An increased risk of HIV
acquisition in pregnant women has implications for health
services as the increased viral load in acute infection would
expose the fetus to higher risk of in utero mother-to-child
transmission [9]. This would also have implications for HIV
epidemic modelling as estimates for paediatric HIV would need
to be revised upwards.
A number of prospective studies from Eastern and Southern
Africa have assessed the risk of HIV incidence during
pregnancy. A multisite study of sero-discordant couples found
that HIV incidence was, in univariate analysis, two-fold higher
in pregnant than in not-pregnant women; however, after
adjusting for age, any unprotected sex in last month, and
contraceptive use, the risk difference was reduced and no
longer statistically significant [5]. A similar study in Uganda
restricted to married sero-discordant couples reported a non-
significant increase in the HIV acquisition rate in pregnant
women [2]. Other studies included women regardless of the
partners’ HIV status; in a Ugandan study of sexually-active
women the risk of HIV-1 acquisition was doubled during
pregnancy [2]. However, in an HIV prevention trial enrolling
women from a number of health services and community
venues in southern Africa there was no increased risk of HIV-1
in pregnant women [7]. A study in Uganda and Zimbabwe, in
which women from family planning sites were enrolled, found
no increased risk of HIV acquisition in pregnant women in the
pooled analysis overall, and actually showed some evidence of
a protective pregnancy effect in one of the sites in the study
after adjusting for covariates [4]. Further studies have shown a
possible increased HIV incidence during pregnancy [10-12],
others showed a risk comparable to the general population of a
similar age [13,14].
A number of studies have investigated HIV incidence in the
postpartum period, again with somewhat conflicting results. In
Malawi, a prospective study of women enrolled after delivery
found HIV acquisition was increased in the first year
postpartum decreasing subsequently [8]; this was also the case
in Zimbabwe [6] and Rwanda [3]. The authors of the latter
study suggested that the decrease could be partly due to a
cohort selection bias with those remaining uninfected for longer
having a lower risk of infection . Other studies have not
reported an increased risk in the postpartum period [2,15].
The rate of HIV acquisition and differences between
pregnant, postpartum and non-pregnant women at a population
level will depend not only on the risk of infection per sexual act
with an HIV positive partner, but also on the level of
discordance in pregnant and non-pregnant couples and the
differences in sexual behaviour between these groups.
Therefore results from the studies outlined above cannot be
generalised to the general population.
Population-based HIV cohort studies are ideally placed to
provide generalisable estimates of the risk of HIV during
pregnancy in the community; this paper uses data from six
such cohorts from eastern and southern Africa. We aim to
assess the population-level HIV incidence during pregnancy
and the post-partum period, adjusting for age. The results will
inform organisations that provide estimates to health services
providers.
Methods
Data
Data come from six sites: Karonga (Karonga prevention
study), Kisesa (TAZAMA), Masaka (UK Medical Research
Council and Uganda Virus Research Institute), Rakai (Rakai
Health Sciences), Manicaland (Imperial College London and
the Biomedical Research and Training Institute) and
uMkhanyukude (Africa Centre). Data collection was sufficiently
similar to allow pooled analyses, with allowance for unobserved
heterogeneity between sites.
The Karonga Demographic Surveillance Study (DSS) is
located in rural northern Malawi; it was established in 2002 and
has a total population of around 35,000, population-based HIV
testing in the DSS was undertaken in four annual rounds from
2007-2011 [16] and average adult HIV prevalence between
these dates was 8% [17]. The Kisesa cohort study is situated in
rural north-west Tanzania, it was established in 1994 and has a
population of around 30,000 it contains a small trading centre
located on the main road from Mwanza town to the border of
Kenya which runs through the centre of the study area,
average HIV prevalence between 1994 and 2010 was 6%
[18,19]. The Masaka DSS is located in rural south west
Uganda and was established in 1989. Its initial population was
around 10,000 which then increased to 18,000 when 10
villages were added to the census area [20]. Average HIV
prevalence between 1989 and 2011 was 8% [21]. The Rakai
Health Sciences Program runs the Rakai Community Cohort
Study (RCCS), with an adult population of between
12,000-16,000. For this analysis, data were collected from
1999 with 2002/3 adult HIV prevalence reported to be 11.4 %
[22]. The Manicaland study was established in 1993. A
prospective household census (population size approximately
37,000) and general population cohort survey (10,000-12,000)
were initiated in 12 locations spread across three districts in
1998, with follow-ups being conducted every 2 or 3 years. They
comprise two small towns, four agricultural estates, two
roadside settlements and four subsistence farming areas.
Overall adult HIV prevalence has fallen in these areas from
24% in the late 1990s to 14% at the end of the 2010s [23]. The
Africa Centre Surveillance study was established in 2000 in
uMkhanyakude, in rural KwaZulu-Natal, South Africa; each
round covers approximately 90,000 resident and non-resident
household members in approximately 12,000 households, with
a key-household respondent [24], an individual HIV
surveillance for resident adults (≥15 years) was added in 2003
and adult HIV prevalence in 2012 was around 28% and annual
incidence in the 15-50 year age group for women was about
5% [25].
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Ethics statement
Each of the six sites contributing data to the pooled analysis
has received ethical clearance from the appropriate local ethics
review bodies, and from the corresponding Institutional Review
Boards for studies which had collaborating partnerships with
Northern Universities.
uMkhanyakude.  Annually re-certified ethics permission for
the Africa Centre DSS and nested individual HIV surveillance
among consenting adults obtained from the Biomedical
Research Ethics Committee at the Nelson Mandela School of
Medicine, University of KwaZulu-Natal. Detailed written
informed consent obtained for participation in the HIV
surveillance.
Karonga.  Ethical approval granted by the National Health
Sciences Research Committee of Malawi and the ethics
Committee of the London School of Hygiene and Tropical
Medicine. Written informed consent obtained for HIV testing.
Kisesa.  Ethical approval for each survey round of the
Kisesa cohort study granted by the Tanzanian Medical
Research Coordinating Committee and the Ethics Committee
of the London School of Hygiene and Tropical Medicine. Prior
to 2006, verbal consent obtained directly from all study
participants (aged 15 and over), due to low literacy rates
among the study population. Consent witnessed and
documented for each study participant by a member of the
sero-survey team. From 2006 onward, consent was again
obtained directly from all study participants, however written
consent option introduced, for those able to provide this.
Manicaland.  All respondents (all aged 15 years and older)
provided written informed consent at each survey round prior to
completing survey and providing a blood sample for HIV
testing. For respondents under age 18 years, written informed
consent was also provided by parent/guardian. Ethical approval
for Manicaland HIV/STD Prevention Project provided by
Medical Research Council of Zimbabwe and St. Mary’s
Research Ethics Committee, London.
Masaka.  The MRC DSS approved by the Uganda Virus
Research Institute (UVRI) Science and Ethics Committee
(SEC) and the Uganda National Council of Science and
Technology (UNCST). Study participants provided written
consent to participate in any part of the study.
Rakai.  The Rakai Community Cohort Survey approved by
the UVRI SEC andUNCST. Literate participants provided
written consent while those unable to read or write had a
witness sign on their behalf.
Identifying pregnancy periods
For all the sites, in the absence of active pregnancy
reporting, pregnancy periods can be identified from the date of
birth of a child. This information either comes from a mother-
child data link or from a women reporting that she gave birth.
All studies apart from Karonga and Africa Centre also collect
routine data on current pregnancy status, giving limited
information on pregnancy periods that do not result in a live
birth. Such pregnancies are harder to identify for a number of
reasons: firstly women rarely report a pregnancy in the first
trimester; secondly many DSS use proxy respondents so it is
possible that they will not know the women in their household is
pregnant until sometime past the first trimester. Pregnancies
ending in early miscarriage are thus rarely captured. Rakai is a
partial exception as they have done routine hCG (human
chorionic gonadotropin) testing if the last menstrual period was
delayed or the woman was unsure of her pregnancy status [2].
Pregnancies ending in stillbirth may be captured either by
asking direct questions about stillbirths since the last DSS
round, or by noting reported pregnancies that did not result in a
live birth in a later round. However only those DSS which have
consistently maintained a short time gap between survey
rounds (ideally ≤4 months) can be reasonably certain of
interviewing women after the first trimester but before the
stillbirth occurs. Early miscarriage and abortion are estimated
to make up a fairly small proportion of total time pregnant
therefore missing a large fraction of these would be unlikely to
affect the results.
Analysis methods
Women of reproductive age (15- 49 years old) were eligible
for inclusion in the analysis. Person-years of observation for
each woman were split into time not-pregnant, pregnant and
one year postpartum. For a woman to be included in the
analysis she must have had at least two HIV tests, the first of
which must have been negative to allow observation of any
sero-conversion. Follow-up time started from the date of the
first negative test and lasted until exit at the date of their last
test or at the date of sero- conversion, if earlier.
Time between HIV surveillance tests varies across the
different sites ranging from annual to three year inter-test
intervals; further, a person might miss a surveillance round thus
extending the period between tests. For all study sites, the
interval between HIV tests is longer than a full gestation
pregnancy, and we cannot be sure whether the sero-
conversion occurred before, during or after the pregnancy
period. To allow for this uncertainty, the analysis was repeated
100 times, each time with the estimated sero-conversion date
assigned at a random point between the last negative and first
positive dates, rates and crude and adjusted hazard rate ratios
(HRR) were calculated using piecewise exponential regression,
so that age (grouped into conventional five year age groups),
pregnancy status and calendar time could be treated as time-
varying factors. Rates and the log of the hazard rate ratios from
the imputations were combined using Rubin’s rules [26] to give
confidence intervals that reflect the uncertainty about the exact
date of sero-conversion. The crude hazard rate ratios
converged at around 20 imputations with the adjusted rate
ratios taking 30 to 40 imputations to converge to stable values.
Since the introduction of widespread voluntary counselling
and testing and the roll-out of antiretroviral treatment (ART) in
sub-Saharan Africa, it is possible that the composition of those
who do not consent to test/participate in surveillance has
changed, potentially biasing results. For example, people who
know they are HIV-positive may be less likely to consent to
participate in an HIV surveillance round [17,27,28], this would
be especially pertinent for women who are HIV tested in
antenatal care (ANC) clinics in the context of prevention of
mother-to-child transmission (PMTCT) services. Women who
are not pregnant may have less exposure to HIV testing,
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although community-based HIV testing is becoming more
widespread. The possibility of bias after PMTCT programmes
were introduced (post-PMTCT period) is addressed by
stratifying the data by the pre- and post-PMTCT periods. Post-
PMTCT is defined from the point when PMTCT became
available and accessible to the populations. In some studies,
this time preceded introduction of HIV treatment programmes
(Masaka, Rakai and uMkhanyakude).
Surveillance data from the Kisesa, Masaka, Manicaland and
Rakai studies all include a period before PMTCT was widely
available at ANC. For Karonga and uMkhanyakude HIV
surveillance data are only available after introduction of
widespread PMTCT services (table 1).
This paper investigates the risk of HIV acquisition during
pregnancy and in the postpartum period in both the pre- and
post-PMTCT period. For the pre-PMTCT period person years
are censored at date of last test prior to widespread PMTCT.
The post-PMTCT period includes all the person years from the
date PMTCT began to be more widely available in each site.
Results
Table 2 and Table 3 show site specific and pooled rates
before and after introduction of PMTCT. Overall there were
2628 sero-conversions and a total of 178 thousand person
years contributing to the analysis. The number of person years
and sero-conversions in the pre-PMTCT period is lower than in
the post-period, partly due to fewer study sites contributing and
partly due to the strict censoring at last test prior to PMTCT
beginning in each site. uMkhanyakude contributes around two-
thirds of the sero-conversions in the post-PMTCT period, but
only a sixth of the person-years due to its relatively high
incidence and low fertility setting. Karonga only provides a
small number of sero-conversions and few person-years due to
a shorter follow-up time. Using the mean of the imputation runs
304 sero-conversions occurred in the 25,000 person years
spent pregnant.
In the pooled data, the crude analysis showed no evidence
of different risks of HIV acquisition between pregnant or
postpartum women and non-pregnant women in the pre-
PMTCT era (Table 4). After adjusting for age, the rate ratios
showed a protective effect for pregnant and postpartum women
compared to those who were not pregnant, although this did
not reach statistical significance for pregnant women (HRR
0.85, 95%CI 0.63-1.13 and HHR 0.75 95%CI 0.57-0.98,
respectively). In the post-PMTCT period, there was evidence of
a protective effect against HIV acquisition in both pregnant and
postpartum women when adjusted for age (HHR 0.60, 95%CI
0.50-0.71 and HHR 0.71 95%CI 0.62-0.82 respectively (Table
5)). After adjusting for study site the evidence became of
borderline statistical significance for postpartum women.
Combining all data from all periods gave results very similar
to those in the post-PMTCT period: with a rate ratio comparing
pregnant to non-pregnant women adjusted by age of 0.69
(95%CI 0.61-0.78), indicating a lower HIV acquisition risk
Table 1. Data available from sites by periods in which availability of PMTCT was low medium and high.
Site Availability of data by level of PMTCT services
 None/Very low Some/Widespread
Karonga No data available 2007-2011
Kisesa 1994-May2007 June 2007-2010
Manicaland 1998-2008 No data available
Masaka 1989-Mar2002 April 2002-2010
Rakai 1999-May2004 June 2004-2011
uMkhanyakude No data available 2001-2011
doi: 10.1371/journal.pone.0082219.t001
Table 2. Sero-conversion and person years contributing to the analysis for each period (mean of imputation runs).
  All* (Six Sites)  Pre PMTCT (Four sites)  Post PMTCT (Five sites)
 Pregnancy and Maternity Status SC 1000 PY Rate /1000  SC 1000 PY Rate /1000  SC 1000 PY Rate /1000
Maternity Status            
 Not pregnant 1861 121.10 15.37  271 28.33 9.57  1245 68.43 18.20
 Pregnant 304 24.75 12.28  62 6.65 10.32  169 12.52 13.46
 <1 year post partum 463 31.49 14.70  81 8.30 8.87  262 16.52 15.86
Pregnancy Status            
 Not pregnant 2324 152.57 15.23  345 36.63 9.41  1507 84.95 17.74
 Pregnant 304 24.75 12.28  69 6.65 10.32  169 12.52 13.46
Note that the uMkhanyakude and Karonga site only contributes to the post PMTCT period.
* Note that all is not the sum of pre and post- PMTCT due to the nature of censoring for the pre-PMTCT group.
doi: 10.1371/journal.pone.0082219.t002
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during pregnancy (Table 6). This effect remained when
adjusting by study site.
There was evidence of an interaction between age and
pregnancy status indicating that the protective effect did not
apply to the 15-24 year old age group (all periods pooled HRR
0.84 95%CI 0.50-1.41), this effect remained significant
excluding the uMkhayakude which contributes the most data.
There was no evidence of interaction between pregnancy
status and study site. The analysis was repeated on individual
site data combining the pre- and post-PMTCT periods (Table
7); both the Kisesa and Rakai studies individually showed a
significant decrease in HIV acquisition rates comparing
pregnant to non-pregnant women when adjusted for age (HRR
0.57, 95%CI 0.37-0.87 and HRR 0.71 , 95%CI 0.57-0.89
respectively). Masaka and Manicaland showed a non-
significant decrease in HIV acquisition, Karonga and Africa
Centre showed no evidence for any difference between HIV
acquisitions in pregnant women compared to non-pregnant
women; however, the confidence intervals in Karonga are very
wide due to the small sample. Kisesa showed a significant
decrease and Masaka a borderline significant decrease in HIV
acquisition in postpartum compared to non-pregnant women;
the other sites showed no evidence for any difference between
the two groups.
Table 3. Number of Sero-conversions (SC) and person years (PY) contributing to the analysis for each site by period (mean
of imputation runs).
  Karonga  Kisesa  Manicaland  Masaka  Rakai  uMkhanyakude
 
Pregnancy
and Maternity
Status SC  
1000
PY   
Rate
per
1000
PY   SC  
1000
PY  
Rate
per
1000
PY   SC  
1000 PY
  
Rate per
1000
PY   SC  
1000
PY  
Rate
per
1000
PY   SC  
1000
PY  
Rate per
1000
PY   SC  
1000
PY  
Rate
per
1000
PY  
Pre PMTCT                        
 Notpregnant - - -  57 6.30 9.06  84 6.08 13.80  65 9.16 7.05  65 6.80 9.57  - - -
 Pregnant - - -  12 2.06 5.85  10 0.55 18.31  11 1.88 5.84  36 2.18 16.55  - - -
 <1 year postpartum - - -  17 2.64 6.50  7 0.74 9.99  13 2.30 5.54  36 2.63 13.88  - - -
Post PMTCT                        
 Notpregnant 34 8.15 4.22  19 3.13 5.93  41 3.70 11.10  83 13.43 6.16  230 20.43 11.26  841 19.70 42.69
 Pregnant 9 1.73 4.99  3 0.65 3.99  1 0.34 1.75  16 2.42 6.44  36 5.31 6.80  105 2.04 51.43
 <1 year postpartum 9 2.46 3.55  6 0.94 6.77  2 0.44 4.24  20 3.22 6.19  80 6.64 11.98  146 2.75 52.88
All Years                        
 Notpregnant 34 8.15 4.22  170 17.33 9.78  241 16.95 14.20  175 25.51 6.88  401 33.44 11.99  841 19.70 42.69
 Pregnant 9 1.73 4.99  36 5.19 6.84  23 1.55 14.65  31 4.84 6.40  100 9.40 10.64  105 2.04 51.43
 <1 year postpartum 9 2.46 3.55  53 6.52 8.10  39 2.11 18.46  38 6.17 6.20  178 11.47 15.55  146 2.75 52.88
Note that each site covers a different period of calendar time.
doi: 10.1371/journal.pone.0082219.t003
Table 4. Incident rate ratio comparing pregnancy status for pre PMTCT period.
Pregnancy and Maternity Status Crude  Adjusted Age  Adjusted Age and Site
 HRR 95% CI  HRR 95% CI  HRR 95% CI
Maternity Status         
Not pregnant 1   1   1  
Pregnant 1.08 (0.82-1.42)  0.85 (0.64-1.13)  0.89 (0.67-1.19)
<1 year post partum 0.93 (0.71-1.21)  0.75 (0.57-0.98)  0.78 (0.59-1.03)
Pregnancy Status         
Not pregnant 1   1   1  
Pregnant 1.10 (0.84-1.43)  0.93 (0.71-1.22)  0.96 (0.73-1.26)
doi: 10.1371/journal.pone.0082219.t004
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Discussion
This study is the first to look at risk of HIV acquisition during
pregnancy at a population level, without restricting the analysis
to sexually active women or to sero-discordant couples. These
data show some evidence that, in the whole population,
pregnant women have a lower risk of HIV acquisition during
pregnancy than women who are not pregnant and no evidence
Table 5. Incident rate ratio comparing pregnancy status for the period post widespread PMTCT.
Pregnancy and Maternity Status Crude  Adjusted Age  Adjusted Age and Site
 HRR 95% CI  HRR 95% CI  HRR 95% CI
Maternity Status         
Not pregnant 1   1   1  
Pregnant 0.74 (0.63-0.87)  0.60 (0.50-0.71)  0.75 (0.64-0.89)
<1 year post partum 0.87 (0.76-1.00)  0.71 (0.62-0.82)  0.89 (0.77-1.02)
Pregnancy Status         
Not pregnant 1   1   1  
Pregnant 0.76 (0.64-0.89)  0.65 (0.55-0.76)  0.77 (0.65-0.91)
doi: 10.1371/journal.pone.0082219.t005
Table 6. Incident rate ratio comparing pregnancy status for all periods.
Pregnancy and Maternity Status Crude  Adjusted Age  Adjusted Age and Site
 HRR 95% CI  HRR 95% CI  HRR 95% CI
Maternity Status         
Not pregnant 1   1   1  
Pregnant 0.80 (0.71-0.90)  0.64 (0.57-0.73)  0.77 (0.68-0.88)
<1 year post partum 0.96 (0.86-1.06)  0.78 (0.70-0.87)  0.92 (0.84-1. 03)
Pregnancy Status         
Not pregnant 1   1   1  
Pregnant 0.81 (0.71-0.91)  0.69 (0.61-0.78)  0.79 (0.70-0.89)
doi: 10.1371/journal.pone.0082219.t006
Table 7. Incident rate ratio adjusted for age comparing pregnancy status for all periods by study site.
 Karonga Kisesa Manicaland Masaka Rakai uMkhanyakude
Pregnancy and Maternity Status HRR 95% CI HRR 95% CI HRR 95% CI HRR 95% CI HRR 95% CI HRR 95% CI
Maternity Status             
Not pregnant 1  1  1  1    1  
Pregnant 1.17 (0.49-2.79) 0.70 (0.47-1.03) 1.02 (0.62-1.68) 0.93 (0.62-1.39) 0.89 (0.71-1.11) 1.20 (0.97-1.48)
<1 year post partum 0.82 (0.33-2.04) 0.83 (0.60-1.14) 1.29 (0.90-1.86) 0.90 (0.63-1.29) 1.30 (1.08-1.55) 1.24 (1.03-1.48)
Pregnancy Status             
Not pregnant 1  1  1  1  1  1  
Pregnant 1.21 (0.51-2.86) 0.66 (0.43-0.99) 0.98 (0.60-1.62) 0.95 (0.64-1.40) 0.82 (0.66-1.03) 1.17 (0.95-1.44)
Adjusted             
 Karonga Kisesa Manicaland Masaka Rakai uMkhanyakude
Pregnancy and Maternity Status HRR 95% CI HRR 95% CI HRR 95% CI HRR 95% CI HRR 95% CI HRR 95% CI
Maternity Status             
Not pregnant 1  1  1  1    1  
Pregnant 0.97 (0.40-2.40) 0.56 (0.38-0.84) 0.81 (0.49-1.34) 0.76 (0.50-1.15) 0.73 (0.58-0.92) 0.91 (0.73-1.12)
<1 year post partum 0.67 (0.26-1.72) 0.68 (0.48-0.95) 1.04 (0.72-1.50) 0.74 (0.51-1.09) 1.08 (0.89-1.30) 0.94 (0.78-1.13)
Pregnancy Status             
Not pregnant 1  1  1  1  1  1  
Pregnant 1.08 (0.45-2.60) 0.57 (0.37-0.87) 0.80 (0.48-1.33) 0.82 (0.55-1.23) 0.71 (0.57-0.89) 0.92 (0.74-1.13)
doi: 10.1371/journal.pone.0082219.t007
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that postpartum women have a different risk of HIV acquisition
in the first year post-pregnancy compared to non-pregnant
women.
A study by Mugo et al. found an unadjusted rate ratio of 2.34
(95% CI 1.33-4.09) comparing pregnant to non-pregnant
women [5], however, this study enrolled sero-discordant
couples with at least three reported episodes of vaginal
intercourse during the three months prior to screening and who
intended to remain a couple and thus were a selected
population. In the population overall, pregnancy is more likely
to be desired in a stable partnership such as marriage. Being in
a stable partnership would imply that the couple have had sex
on a frequent basis, and, therefore by the time of a pregnancy,
will be more likely to be sero-concordant with their partner. The
higher the parity of the birth, the more likely the couple are to
be HIV concordant (if the births have occurred within the same
partnership) as they will have had a longer period of sexual
partnership. Assuming that a higher proportion of pregnant
women are in stable partnerships than non-pregnant women, it
is likely that a higher proportion of pregnant women have sero-
negative partners compared to the non-pregnant women. This
is because those already concordant-positive will not be at risk
of infection and therefore will be excluded from the analysis.
The interaction evidence that the slight protective effect is not
seen in the youngest age group might go further to support this
theory as they have had less time to become concordant with
their partner. Also those who have never had a sexual partner,
a relatively large fraction of the under-20 age group, will not be
at risk of infection and will not be pregnant.
Studies of sexually active women are less selective than
sero-discordant couple studies but could still be different to
those based on the whole population. The definition of sexually
active women varies across studies, some exclude all women
who report no sexual activity in the intervals between survey
rounds, which may cause the exclusion of women who report
no sexual activity during or immediately after pregnancy [2],
some exclude only women who did not have a partner in the
last 12 months [7], and some exclude those who were not
sexually active at enrolment [4] with the time reference period
left unspecified. If all sexually inactive women in both the non-
pregnant and pregnant groups were excluded, differences in
the age-specific proportion sexually inactive in the two groups
could give rise to spurious results. Pregnant women or those
who had recently given birth might be less sexually active due
to the pregnancy, especially in cultures where prolonged post-
partum abstinence is the cultural norm [29]. Non-pregnant
women may be excluded because they have never had a
sexual partner – in these two cases the excluded women are at
lower risk of infection. But in other cases, exclusion of women
retrospectively reporting no recent sexual activity may lead to
excluding high risk groups: e.g. women whose marriages have
recently broken up due to widowhood and separation (these
events occur more frequently among women with HIV positive
partners [30]); or women who live apart from their partners
because of the nature of their employment [31]. The
prospective behaviour of women who have recently
experienced a period without sexual activity may also place
them at high risk in the near future e.g. at the time of first sex or
when acquiring a new partner [32].
Using sexually active women from sites in Uganda and
Zimbabwe Morrison et al [4] overall found no difference
between the pregnant and not pregnant women (HRR 0.56
95% CI 0.30-1.05); however, they did find evidence for an
interaction with site; the Zimbabwean site showed a lower risk
of HIV acquisition in pregnant women (HR 0.26; 95% CI
0.10-0.68). As with this study they also found some evidence of
interaction with age, with no difference in HIV acquisition for
younger women (HRR 1.14; 95% CI 0.47-2.80) but a lower risk
during pregnancy for older women (HRR 0.37 95% CI
0.13-1.09); however, this was not statistically significant. A
further prospective study found no increased risk [7]. Only one
prospective study of sexually active women in Uganda found a
significant increased risk in HIV transmission during pregnancy
(HRR 2.03 95% CI% 1.33-3.11) unadjusted and a similar result
after adjusting for covariates [2]. The study shows that when
stratifying by age the rate ratio only remains statistically
significant for those 15-19 years old, showing a similar age
effect to this study and to the study by Morrison et al [4]. The
Ugandan study sample of sexually active women [2] came from
the same population as the Rakai study in this analysis at an
earlier time period but gives an increased risk of HIV
acquisition in pregnant women rather than the decreased risk
we see in this analysis when using the whole population.
In this analysis overall, we find no evidence of increased HIV
incidence in the post-partum period when compared to non-
pregnant and non-postpartum periods. There was some
evidence of a decreased risk in this period once adjusted for
age; however, statistical significance was lost when also
adjusting for site indicating heterogeneity between study sites.
To be consistent with studies that found a higher incidence
immediately postpartum followed by a decrease over time, we
would expect to see a significantly higher incidence in women
in the post-partum period than in women who were neither
pregnant nor post-partum. There are a number of differences in
the studies cited above: those noting an increase in risk are not
from the general population but from antenatal clinics or
hospital delivery wards, therefore restricting the analysis to
women who have given birth, whereas in this study the non-
pregnant non-postpartum women may never have given birth
or last gave birth a long time ago. Also it is possible, as Leroy
et al suggest [3], that studies noting a decrease in incidence
over time could be affected by a cohort selection effect
whereby high risk sub-groups sero-convert early on, leaving
the cohort survivors composed mainly of low risk sub-groups.
Finally, the incident rate confidence intervals in these studies
either overlapped between groups [3] or are not shown [8];
therefore, the results give weak but inconclusive evidence. Our
results here are consistent with a study of sexually active
women in Uganda [2] which showed no significant difference in
those women breastfeeding compared to those not pregnant
and non-lactating.
The major strength of this study is that it is population-based
rather than selected from clinics or hospitals, therefore we are
able to assess the population risk of HIV transmission during
pregnancy. Also we have pooled data from six different study
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sites that contribute 178,000 person years of data which makes
this study much larger than previous studies on this topic.
Four sites were able to contribute to the pre-PMTCT period,
where there is less possibility of bias due to those who know
they are infected being less likely to agree to testing, however
the results from the pre- and post-analysis were consistent
although the pre-PMTCT period did not reach statistical
significance because of the limited sample size available. If
there was a bias in the post-PMTCT period it would have to be
very large to overturn the protective effect of pregnancy shown
in this study (HRR 0.65; 95%CI 0.61-0.78) and generate an
increased risk of around two as seen in the sero-discordant
couple studies. Kisesa, one of the study sites that, on its own,
showed a lower risk of HIV acquisition during pregnancy,
actually had one of the shortest periods where PMTCT was
available, therefore it is less likely to be biased due to
differences between pregnant and non-pregnant women
knowing their HIV status and their subsequent participation in
the surveillance study.
The major limitation of this analysis is the source of HIV test
data from surveillance rounds that may be two or three years
apart giving long sero-conversion intervals. Thus, we only know
that a woman was pregnant at some point during the interval
but do not know if the sero-conversion occurred before, during,
or immediately after, the pregnancy. The imputation method
used enables us to allow for this uncertainty and to generate
confidence intervals to reflect this. When restricting the
analysis to shorter sero-conversion intervals, the results did not
change. The identification of a pregnancy interval may also
lead to uncertainty, pregnancies that end in miscarriage are
rarely reported in these studies, stillbirths are also often not
captured, therefore some of the pregnancy person years will be
miscategorised as not pregnant. However these person-years
will be small in comparison with all the pregnancies identified
by live births and those pregnancies that are captured with a
pregnancy report. HIV infected women suffer more
miscarriages and stillbirths than their uninfected counterparts
[33] however this decrease in viability of pregnancy is
associated with longer duration of infection [34], there are no
studies that suggest an association of sero-conversion with
pregnancy loss.
Although there might be immunological reasons for
increased risk of HIV acquisition during pregnancy, at a
population level this study indicates a lower risk of HIV
acquisition in pregnant women. This is probably due to a range
of socio-behavioural characteristics of women and their
partners that determine which women are most likely to
become pregnant and which women will become infected, and
these factors could be investigated in further analyses.
This study furthers understanding of the population risk of
HIV acquisition during pregnancy and in the first year
postpartum. The results can inform modellers and help health
care providers with decisions on the kinds of interventions that
would do most to help prevent the spread of HIV.
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